KORA CORPORATION LIMITED

Kora Healthcare is an emerging, internationally-focused life-sciences company dedicated to identifying, developing and commercialising high-quality medicines. By targeting secondary conditions that arise from serious, chronic diseases, as well as sexual and reproductive health issues for both women and men, Kora aims to enhance patients' quality of life across a broad therapeutic spectrum.

The firm's value proposition centres on a robust product portfolio and a forward-looking pipeline, underpinned by a culture of innovation, rigorous quality standards and a commitment to sustainability. Recent milestones include successful completion of the NHS Evergreen Sustainable Supplier Assessment, the launch of a 2024 NHS carbon-reduction plan, and EU MDR certification for its Relactagel product.

Guided by a vision of sustainable, growth-orientated development, Kora Healthcare strives to anticipate and respond efficiently to patient needs, delivering reliable therapeutic solutions that make a tangible difference to wellbeing worldwide.